Perrigo Company plc Gain (Loss) on Investments
Perrigo Company plc (PRGO) reported Gain (Loss) on Investments of -$4.10 million for the 3-month period ending 2015-09-26, per its 10-Q filed 2015-11-02.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnInvestments · last filed 2015-11-02
- Perrigo Company plc gain (loss) on investments for the quarter ending 2015-09-26 was -$4.10M.
- Perrigo Company plc gain (loss) on investments for the quarter ending 2015-03-28 was -$300.00K.
- Perrigo Company plc gain (loss) on investments for the quarter ending 2014-12-27 was -$3.10M.
- Perrigo Company plc gain (loss) on investments for the quarter ending 2014-09-27 was -$3.10M.
| Period end | Gain (Loss) on Investments 3 month | Gain (Loss) on Investments 6 month | Gain (Loss) on Investments 9 month |
|---|---|---|---|
| 2015-09-26 | -$4.10M 10-Q · filed 2015-11-02 | ||
| 2015-03-28 | -$300.00K 10-Q · filed 2015-04-29 | -$3.40M derived: sum of 2 quarters · filed 2015-04-29 | -$6.60M 10-Q · filed 2015-04-29 |
| 2014-12-27 | -$3.10M 10-Q · filed 2015-02-05 | -$6.30M 10-Q · filed 2015-02-05 | |
| 2014-09-27 | -$3.10M 8-K · filed 2014-11-20 | ||
| 2013-09-28 | $0.00 8-K · filed 2014-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |